Clin2
NCT06992531Possibly a fitNot yet recruiting

Immune system study for PoTS and fibromyalgia symptoms

Postural Orthostatic Tachycardia Syndrome (POTS)Fibromyalgia (FM)

Part of Bones, joints & muscles, Brain & nervous system clinical trials.

This study looks at how the immune system might play a role in symptoms like dizziness (PoTS) and widespread pain (fibromyalgia). By comparing people with these conditions to healthy volunteers, they hope to find better ways to understand and treat these symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
250 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You must be between 18 and 80 years old.
  • You must be able to understand and sign a consent form.
  • You must be diagnosed with PoTS or Fibromyalgia (or be a healthy volunteer).
  • You must not have any autoimmune or skin conditions like psoriasis or lupus.
  • You must not have nerve damage conditions such as diabetes or vitamin B12 deficiency.
  • You must not be pregnant or taking blood thinners.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06936319Recruiting
Body movements for POTS symptom control

This study tests simple body movements (like squeezing your legs or squatting) to see if they help control POTS symptoms. It may offer a non-drug way to manage dizziness and fast heart rate when standing.

Innsbruck, Tyrol
NCT07757555Not yet recruiting· Early Phase 1
Two medicines for recent-onset POTS with allergy symptoms

This early-stage trial tests two medicines (guanfacine and cromolyn sodium) to see if they help with POTS symptoms like dizziness and rapid heartbeat. It's looking for people whose POTS started recently after a trigger and who may have signs of allergic-type reactions.

Baltimore, Maryland
NCT07585513Not yet recruiting· Phase 2
Beta-blocker-like treatment for POTS

This study tests whether a daily pill called mirabegron can help control the rapid heartbeat and other symptoms of postural orthostatic tachycardia syndrome (POTS). If you join, you'll take the study drug or a placebo for a set time and track your symptoms.

NCT02725060Enrolling by invitation
Study of autoimmune changes in postural tachycardia syndrome

This trial studies whether an autoimmune (immune system–related) process is involved in postural tachycardia syndrome (POTS), a condition where your heart rate rises when you stand. The study may help researchers understand what causes POTS and how it could be treated or monitored.

Oklahoma City, Oklahoma
NCT06616363Recruiting
Brain and nerve connection in POTS and after infection

This study looks at why some people develop POTS (a condition that causes a fast heart rate and dizziness when standing) and if it's linked to how the brain and vagus nerve work together. It also includes people recovering from a serious infection and healthy volunteers for comparison.

Richmond, Virginia
NCT06851091Recruiting
Fibromyalgia study on pain sensitivity and balance

This study looks at how fibromyalgia affects your sensitivity to pain and your sense of balance. It may help find better ways to treat these symptoms.

Istanbul, Üsküdar

Hear when a new Fibromyalgia (FM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.